Inclusion Criteria:  Willing to participate in the study being 18 and over  For overweight/obese adults (BMI≥25kg/m2)  without self-reported diagnosis of Type 2 Diabetes (T2D) or Chronic Kidney Disease (CKD): Estimated Glomerular Filtration Rate (eGFR)≥90mL/min/1.73m2 and urine albumin to creatinine ratio (ACR)<30mg/g within the past 12 months with Type 2 Diabetes (T2D) but without Chronic Kidney Disease (CKD): Estimated glomerular filtration rate (eGFR)≥90mL/min/1.73m2 and Albumin-to-Creatinine ratio (ACR)<30mg/g within the past 12 months with early stage Chronic Kidney Disease (CKD): 60≤eGFR<90mL/min/1.73m2 or 30mg/g ≤ACR< 1000mg/g within the 12 months can speak and understand English own a smart phone or tablet that has reliable internet/data access agree to comply with all study requirements  Exclusion Criteria:  Patients with triglyceride ≥ 500 mg/dL or with Low-Density Lipoprotein Cholesterol≥ 129mg/dL type 1 diabetes (by self-report) severe psychiatric disorders deemed by investigators, which might interfere with study procedures (by self-report) severe chronic conditions (e.g. severe heart disease, renal disease, cognitive impairment, etc.) that would preclude them from participating unwillingness to sign the consent form and be randomized into a study group enrollment in other low carb/keto diet or weight loss programs inability to walk without assistance (by self-report) under SGLT2 inhibitor treatment being pregnant or breast feeding (by self-report) having plans to leave the city or USA for over 2 weeks within 6 months at enrollment